Seladelpar Achieves Primary, Secondary Endpoints in Phase 3 RESPONSE Trial
Results from RESPONSE show seladelpar may improve measures of disease activity and reduce symptom burden in patients with PBC.
Stay updated with breaking news from Randomized Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Results from RESPONSE show seladelpar may improve measures of disease activity and reduce symptom burden in patients with PBC.
Losing weight can help manage your sleep apnea. But how much weight loss is needed to stop sleep apnea symptoms?
– Data Across 30 Abstracts Reinforce Leadership in Metastatic Breast Cancer and Demonstrate Breadth of Pipeline Across Lung, Hematologic, Genitourinary, Gastrointestinal, Gynecological and... | May 17, 2023
/PRNewswire/ -- The Cambia Health Foundation has announced the selection of 12 emerging palliative care leaders for its Sojourns® Scholar Leadership Program....
The scholars represent the next generation of palliative care leaders and demonstrate the Foundation's commitment to whole-person care for people ...